Advanced Oncotherapy Plc Ord 25P is listed on the London Stock Exchange trading with ticker code AVO.L, and is part of the Health Care and Related Services sector. It has a market capitalisation of £285,621m, with approximately 195m shares in issue. Over the last year, Advanced Oncotherapy Plc share price has been traded in a range of 103.95, hitting a high of 308.95, and a low of 205.00.
Advanced Oncotherapy Plc, officially known as Advanced Oncotherapy Plc Ord 25P was formed in September of 2005, making the company fourteen years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 106 thousand GBX, and a pre-tax profit margin of -5951.26%. Advanced Oncotherapy Plc currently has 10 directors, and has had 12 previous directors over the last 14 years. In the last set of accounts produced by Rpg Crouch Chapman Llp, the company showed 3.94 million paid in salaries to the 23 staff (average wage of 171 thousand), with the directors receiving an average 110 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Advanced Oncotherapy Plc to have a net worth of 1.91 million, with 1.47 million held in cash.
Advanced Oncotherapy Plc is in the Health Care and Related Services sector.
|E-therapeutics Plc (ETX.L)|
|Quadrise Fuels International Plc (QFI.L)|
|Cppgroup Plc (CPP.L)|
|Tasty Plc (TAST.L)|
|Silence Therapeutics Plc (SLN.L)|
|Shares in Issue||195m|
|52 Week High||308.95|
|52 Week Low||205.00|